Effectiveness of heterologous coronavirus disease 2019 (COVID-19) vaccine booster dosing in Brazilian healthcare workers, 2021

…, M Polonio, RH Ornelas, SM De Oliveira… - Clinical infectious …, 2023 - academic.oup.com
Background Little is currently known about vaccine effectiveness (VE) for either 2 doses of
Oxford-AstraZeneca (ChAdOx1) viral vector vaccine or CoronaVac (Instituto Butantan) …

[HTML][HTML] Effectiveness of two COVID-19 vaccines (viral vector and inactivated viral vaccine) against SARS-CoV-2 infection in a cohort of healthcare workers.

…, RH Ornelas, SM de Oliveira… - Infect Control Hosp …, 2022 - pesquisa.bvsalud.org
OBJECTIVES: We aimed to investigate real-world vaccine effectiveness (VE) for Oxford-AstraZeneca
(ChAdOx1) and CoronaVac against laboratory-confirmed COVID-19 infection …

[HTML][HTML] Long term persistence of coronavirus SARS-CoV-2 infection

JRR Pinho, KG Oliveira, R Sitnik, MM Maluf… - Einstein (Sao …, 2021 - SciELO Brasil
… infecção por SARS-CoV-2, de 26 de março a 20 de maio de 2020, foi … de longo prazo para
SARS-CoV-2 nos exames de reação em cadeia da polimerase via transcriptase reversa de

Risk factors for long coronavirus disease 2019 (long COVID) among healthcare personnel, Brazil, 2020–2022

…, LW Vieira, M Polonio, SM de Oliveira… - Infection Control & …, 2023 - cambridge.org
Objective:To determine risk factors for the development of long coronavirus disease 2019 (COVID-19)
in healthcare personnel (HCP).Methods:We conducted a case–control study …

Risk factors for long COVID among healthcare workers, Brazil, 2020–2022

…, A Cypriano, LW Vieira, M Polonio, SM de Oliveira… - medRxiv, 2023 - medrxiv.org
Objectives We aimed to determine risk factors for the development of long coronavirus
disease (COVID) in healthcare workers (HCWs). Methods We conducted a case-control study …

Longer-term effectiveness of a heterologous coronavirus disease 2019 (COVID-19) vaccine booster in healthcare workers in Brazil

…, M Polonio, RH Ornelas, SM de Oliveira… - Antimicrobial …, 2023 - cambridge.org
Objective: To compare the long-term vaccine effectiveness between those receiving viral
vector [Oxford-AstraZeneca (ChAdOx1)] or inactivated viral (CoronaVac) primary series (2 …

Effectiveness of two coronavirus disease 2019 (COVID-19) vaccines (viral vector and inactivated viral vaccine) against severe acute respiratory coronavirus virus 2 …

…, M Polonio, RH Ornelas, SM de Oliveira… - Infection Control & …, 2023 - cambridge.org
Objective: We investigated real-world vaccine effectiveness for Oxford-AstraZeneca (ChAdOx1)
and CoronaVac against laboratory-confirmed severe acute respiratory coronavirus virus …

Risk factors for long COVID among healthcare workers, Brazil, 2020 (preprint)

…, KG de Oliveira, RAF Santana, F de Mello Malta… - 2023 - pesquisa.bvsalud.org
Objectives: We aimed to determine risk factors for the development of long coronavirus
disease (COVID) in healthcare workers (HCWs). Methods: We conducted a case-control study …

[HTML][HTML] Molecular characterization of group B Streptococcus serotypes by multiplex polymerase chain reaction

…, JS Russo, JB Gouveia, CRC Costa, KG Oliveira… - …, 2015 - SciELO Brasil
OBJECTIVE: Group B Streptococcus (GBS) serotypes (Ia, Ib and II to IX) are classified based
on variations in their capsular polysaccharide; their prevalence differs between different …

Long term persistence of coronavirus SARS-CoV-2 infection.

JR Rebello Pinho, KG de Oliveira, R Sitnik… - Einstein …, 2021 - search.ebscohost.com
… infecção por SARS-CoV-2, de 26 de março a 20 de maio de 2020, foi … de longo prazo para
SARS-CoV-2 nos exames de reação em cadeia da polimerase via transcriptase reversa de